Does testosterone treatment cause infertility? This is a critical question for men considering testosterone replacement therapy (TRT), particularly those of reproductive age. Whilst TRT effectively treats symptoms of hypogonadism such as fatigue, low libido, and reduced muscle mass, it can significantly impair male fertility through suppression of natural sperm production. Understanding the mechanisms, reversibility, and alternatives is essential for informed decision-making. This article examines how testosterone affects fertility, recovery prospects after stopping treatment, preservation options, and fertility-sparing alternatives available in the UK.

How Testosterone Treatment Affects Male Fertility

Testosterone replacement therapy (TRT) can significantly impair male fertility through a well-understood physiological mechanism. When exogenous testosterone is administered—whether via injections, gels, patches, or implants—the body's natural hormonal feedback system responds by reducing the production of gonadotrophin-releasing hormone (GnRH) from the hypothalamus. This subsequently decreases luteinising hormone (LH) and follicle-stimulating hormone (FSH) secretion from the pituitary gland.

The reduction in LH and FSH has direct consequences for testicular function. LH normally stimulates Leydig cells to produce testosterone locally within the testes, whilst FSH supports Sertoli cells that are essential for spermatogenesis (sperm production). When these hormones are suppressed by exogenous testosterone, intratesticular testosterone levels fall dramatically—often to levels insufficient to maintain sperm production. Studies show that many men on TRT experience oligospermia (low sperm count) or azoospermia (absence of sperm in ejaculate) within 6–12 months of treatment, though rates vary by dose, preparation and individual factors.

This effect occurs regardless of the testosterone formulation used. UK product information for all testosterone preparations (including Nebido, Testogel and Sustanon) warns about potential suppression of spermatogenesis. Men may also notice testicular atrophy (shrinkage) as the testes reduce their activity. It is crucial to understand that whilst testosterone treats symptoms of hypogonadism such as low libido, fatigue, and reduced muscle mass, it simultaneously suppresses sperm production. TRT is not a contraceptive and should not be used by men actively trying to conceive. A baseline semen analysis should be considered before starting treatment, and men of reproductive age should receive comprehensive counselling about fertility implications.

Is Infertility from Testosterone Treatment Reversible?

The encouraging news is that testosterone-induced infertility is often reversible, though recovery is neither guaranteed nor immediate. When testosterone treatment is discontinued, the hypothalamic-pituitary-gonadal (HPG) axis typically begins to recover, allowing natural testosterone and sperm production to resume. However, the timeline and completeness of recovery vary considerably between individuals.

Research suggests that sperm production may return in most men after stopping TRT, but this process can take anywhere from 3 months to 2 years or longer. Factors influencing recovery include the duration of testosterone use, the dosage administered, the formulation used (recovery may be slower after long-acting depot injections), baseline fertility status, age, and individual physiological variation. Men who have used testosterone for shorter periods (less than 12 months) generally experience faster and more complete recovery than those on long-term therapy.

Some men may not fully recover their baseline fertility. Those with pre-existing fertility issues, advanced age (over 40), or prolonged testosterone exposure face higher risks of incomplete recovery. In such cases, sperm counts may improve but remain below optimal levels for natural conception. Regular semen analysis following cessation can monitor recovery progress, with frequency determined by specialist advice.

Medical interventions may help recovery in some cases. Endocrinologists or andrologists may consider treatments to stimulate the testes and restore spermatogenesis more rapidly. These specialist-led treatments might include human chorionic gonadotrophin (hCG) or other medications, some of which are used off-label for this purpose in men. Men concerned about fertility should be referred to an endocrinologist or fertility specialist rather than abruptly stopping therapy without medical supervision.

Fertility Preservation Options Before Starting Testosterone

For men who may wish to father children in the future, fertility preservation should be discussed before initiating testosterone therapy. The most established and effective option is sperm cryopreservation (sperm banking), which involves collecting and freezing semen samples for future use in assisted reproductive techniques. This straightforward procedure is available through NHS fertility services in some areas and private clinics throughout the UK.

Sperm banking typically requires producing 2–3 samples over several days or weeks to ensure adequate storage. The samples are analysed for sperm count, motility, and morphology, then cryopreserved in liquid nitrogen where they can remain viable for decades. Frozen sperm can be effective for future fertility treatment, though success rates vary depending on the technique used (intrauterine insemination, IVF or ICSI), original semen quality, female factors, and other variables. The Human Fertilisation and Embryology Authority (HFEA) regulates UK fertility clinics and provides information on storage limits (up to 55 years with periodic consent renewal) and clinic-specific success rates.

Cost considerations are important, as NHS funding for fertility preservation varies by region and clinical indication. Private sperm banking costs vary widely between clinics, with initial fees plus annual storage charges. Some NHS Integrated Care Boards (ICBs) may fund preservation for medical reasons, though policies differ across the UK. Patients should check local funding arrangements.

Alternative approaches during testosterone therapy require specialist supervision. Some fertility specialists may consider regimens that aim to maintain testicular function whilst addressing hypogonadal symptoms, but these approaches are not universally effective and require careful monitoring. Men should discuss these options with a reproductive endocrinologist or fertility specialist to determine the most appropriate strategy based on individual circumstances, treatment goals, and family planning intentions.

Alternative Treatments That Protect Fertility

For men with hypogonadism who wish to preserve fertility, several alternative treatments can address symptoms whilst maintaining reproductive function. The choice depends on the underlying cause of low testosterone, symptom severity, and individual patient factors. These alternatives work by stimulating the body's own testosterone production rather than replacing it exogenously.

Certain medications may be considered by specialists for men with secondary hypogonadism who need to preserve fertility. These include selective oestrogen receptor modulators (SERMs) such as clomifene citrate, which is used off-label in men in the UK. These medications can increase the body's own testosterone production whilst maintaining sperm production. Side effects may include mood changes, visual disturbances (which require immediate medical attention and discontinuation), or gynaecomastia. These treatments should only be initiated and monitored by specialists in endocrinology or andrology.

Human chorionic gonadotrophin (hCG) therapy mimics LH and directly stimulates testicular Leydig cells to produce testosterone. It can be used alone or combined with other hormones under specialist supervision. This approach is particularly effective for men with certain types of hypogonadism and requires careful monitoring and dose adjustment.

Lifestyle modifications and treatment of underlying conditions should not be overlooked. Weight loss in obese men can significantly improve testosterone levels, as adipose tissue converts testosterone to oestrogen. NHS guidance recommends addressing modifiable factors including obesity, excessive alcohol consumption, and sleep apnoea before considering TRT. Optimising management of chronic conditions such as type 2 diabetes and stress reduction may also improve hormonal balance.

Other specialist options may include aromatase inhibitors for specific cases, though these are used off-label for this purpose in the UK and have limited evidence. Men should be referred to an endocrinologist or andrologist to determine the most appropriate fertility-preserving treatment based on comprehensive hormonal assessment, symptom profile, and reproductive goals. Patients should report any suspected side effects from medications to their doctor or via the MHRA Yellow Card Scheme.

Frequently Asked Questions